|
|
|
|
A more recent version of this article appeared on December 1, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 15, 2003
Revised on July 10, 2003
Accepted on July 25, 2003
1 Dipartimento di Patologia generale, Seconda
Università degli Studi di Napoli, Napoli, Italy
2 Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, USA
* Corresponding author. E-mail address: alessandro.weisz{at}unina2.it.
Estrogens control cell growth and viability in target cells
via a interplay of genomic and extragenomic pathways not
yet elucidated. Here we show evidence that cell proliferation and
survival are differentially regulated by estrogen in rat pituitary
tumor PR1 cells. Pico to femtomolar concentrations of 17
-estradiol
(E2) are sufficient to foster PR1 cell proliferation, whereas nanomolar
concentrations of the same are needed to prevent cell death, that
occurs at high rate in these cells in the absence of hormone.
Activation of endogenous (PRL) or transfected estrogen-responsive genes
occur at the same, higher concentrations of E2 required to promote cell
survival, whereas stimulation of cyclin D3 expression and DNA synthesis
occur at lower E2 concentrations. Similarly, the pure antiestrogen ICI
182,780 inhibits ERE-dependent trans-activation and cell
death more effectively than cyclin-cdk activity, G1-S
transition or DNA synthesis rate. In antiestrogen-treated and/or
estrogen-deprived cells, death is due predominantly to apoptosis.
Estrogen-induced cell survival, but not E2-dependent cell cycle
progression, can be prevented by an inhibitor of c-Src kinase or by
blockade of the MEK/ERK signaling pathway. These data indicate the
coexistence of two distinguishable estrogen signaling pathways in PR1
cells, characterized by different functions and sensitivity to hormones
and antihormones.
This article has been cited by other articles:
![]() |
I. Pellegrini, C. Roche, M.-H. Quentien, M. Ferrand, G. Gunz, S. Thirion, C. Bagnis, A. Enjalbert, and J.-L. Franc Involvement of the Pituitary-Specific Transcription Factor Pit-1 in Somatolactotrope Cell Growth and Death: An Approach Using Dominant-Negative Pit-1 Mutants Mol. Endocrinol., December 1, 2006; 20(12): 3212 - 3227. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chaturvedi and D. K. Sarkar Mediation of Basic Fibroblast Growth Factor-Induced Lactotropic Cell Proliferation by Src-Ras-Mitogen-Activated Protein Kinase p44/42 Signaling Endocrinology, April 1, 2005; 146(4): 1948 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pisera, M. Candolfi, S. Navarra, J. Ferraris, V. Zaldivar, G. Jaita, M. G. Castro, and A. Seilicovich Estrogens sensitize anterior pituitary gland to apoptosis Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E767 - E771. [Abstract] [Full Text] [PDF] |
||||